Angiotensin-converting enzyme (ACE) inhibitors and angiotensin receptor blockers (ARBs) are commonly prescribed to individuals diagnosed with diabetes and hypertension to mitigate proteinuria and decelerate the advancement of kidney disease [25]. Here, ACE is linked to kidney disorder.